Primary Dermal Microvascular Endothelial Cells; Normal, Human, Neonatal (ATCC^® PCS-110-010^™)

Organism: Homo sapiens, human / Tissue: Neonatal foreskin / Cell Type: Endothelial Cells

Primary Dermal Microvascular Endothelial Cells; Normal, Human, Neonatal ATCC^® PCS-110-010^™

frozen 1 mL

For-Profit: $559.00 Non-Profit: $559.00

Qty:

Recommended for this product

Permits and Restrictions	View Permits
Organism	Homo sapiens, human
Tissue	Neonatal foreskin
Cell Type	Endothelial Cells
Morphology	Cobblestone appearance with large dark nuclei; during proliferation, cells are small and evenly sized, display a high mitotic index and show no presence of smooth muscle cells.
Growth Properties	Adherent
Biosafety Level	1 [These primary cells are not known to harbor an agent recognized to cause disease in healthy adult humans. Handle as a potentially biohazardous material under at least Biosafety Level 1 containment. Cells derived from primate lymphoid tissue may fall under the regulations of 29 CFR 1910.1030 Bloodborne Pathogens. ATCC recommends that appropriate safety procedures be used when handling all primary cells and cell lines, especially those derived from human or other primate material. Detailed discussions of laboratory safety procedures are provided in *Laboratory Safety: Principles and Practice, 2nd ed. (ASM Press, Washington, DC)* (Fleming et al., 1995) and Caputo, J.L. Biosafety procedures in cell culture. (1988) J. Tissue Culture Methods 11:223. Appropriate safety procedures should always be used with this material. Laboratory safety is discussed in the following publication: *Biosafety in* *Microbiological and Biomedical Laboratories, 5th ed. HHS Publication No. (CDC) 93-8395. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Washington DC: U.S. Government Printing Office; 2007. The entire text is available online at http://www.cdc.gov/biosafety/publications/bmbl5/index.htm.] Human Material Precaution* All tissues used for isolation are obtained under informed consent and conform to HIPAA standards to protect the privacy of the donor’s personal health information. It is best to use caution when handling any human cells. We recommend that all human cells be accorded the same level of biosafety consideration as cells known to carry HIV. With infectious virus assays or viral antigen assays, even a negative test result may leave open the possible existence of a latent viral genome.
Disease	Normal
Age	Neonatal
Gender	Batch-specific
Ethnicity	Batch-specific
Applications	Drug screening, angiogenesis, oncology, inflammation, intercellular communication
Product Format	frozen 1 mL
Storage Conditions	-130°C or below

Comments	The cells are cryopreserved in the third passage to ensure the greatest purity of the cell population, coupled with high viability and plating efficiency. A complete solution to propagate dermal microvascular cells in low serum (5% FBS) conditions with or without the addition of human recombinant VEGF. Use of the Endothelial Cell Growth Kit-VEGF will support a faster rate of proliferation because of the presence of several purified human recombinant (rh) growth factors (rh VEGF, rh EGF, rh FGF basic and rh IGF-1) combined with heparin and hydrocortisone. Use of the Microvascular Endothelial Cell Growth Kit-BBE, which contains Bovine Brain Extract (BBE), is recommended if a more "authentic," less defined culture medium is desired.

Comments

The cells are cryopreserved in the third passage to ensure the greatest purity of the cell population, coupled with high viability and plating efficiency.

A complete solution to propagate dermal microvascular cells in low serum (5% FBS) conditions with or without the addition of human recombinant VEGF. Use of the Endothelial Cell Growth Kit-VEGF will support a faster rate of proliferation because of the presence of several purified human recombinant (rh) growth factors (rh VEGF, rh EGF, rh FGF basic and rh IGF-1) combined with heparin and hydrocortisone. Use of the Microvascular Endothelial Cell Growth Kit-BBE, which contains Bovine Brain Extract (BBE), is recommended if a more "authentic," less defined culture medium is desired.

Complete Growth Medium

Obtain one growth kit from the freezer; make sure that the caps of all components are tight.
Thaw the components of the growth kit just prior to adding them to the basal medium. It is necessary to warm the L-glutamine component in a 37°C water bath and shake to dissolve any precipitates prior to adding to the basal medium.
Obtain one bottle of Vascular Cell Basal Medium (475 mL) from cold storage.
Decontaminate the external surfaces of all growth kit component vials and the basal medium bottle by spraying them with 70% ethanol.
Using aseptic technique, and working in a laminar flow hood or biosafety cabinet, transfer the volume of each growth kit component, as indicated in either Table 1 or 2, to the bottle of basal medium using a separate sterile pipette for each transfer.

Table 1. If using the Microvascular Endothelial Cell Growth Kit-BBE (ATCC^® PCS-110-040), add the indicated volume for each component:

Component	Volume	Final Concentration
Bovine Brain Extract (BBE)	1.0 mL	0.2%
rh EGF	0.5 mL	5 ng/mL
L-glutamine	25.0 mL	10 mM
Heparin sulfate	0.5 mL	0.75 Units/mL
Hydrocortisone hemisuccinate	0.5 mL	1 µg/mL
Fetal Bovine Serum	25.0 mL	5%
Ascorbic acid	0.5 mL	50 µg/mL

Table 2. If using the Microvascular Endothelial Cell Growth Kit-VEGF (ATCC^® PCS-110-041), add the indicated volume for each component:

Component	Volume	Final Concentration
rh VEGF	0.5 mL	5 ng/mL
rh EGF	0.5 mL	5 ng/mL
rh FGF basic	0.5 mL	5 ng/mL
rh IGF-1	0.5 mL	15 ng/mL
L-glutamine	25.0 mL	10 mM
Heparin sulfate	0.5 mL	0.75 Units/mL
Hydrocortisone hemisuccinate	0.5 mL	1 µg/mL
Fetal Bovine Serum	25.0 mL	5%
Ascorbic acid	0.5 mL	50 µg/mL

Antimicrobials and phenol red are not required for proliferation but may be added if desired. The recommended volume of each optional component to be added to the complete growth media is summarized in Table 3.

Table 3. Addition of Antimicrobials/Antimycotics and Phenol Red (Optional)

Component	Volume	Final Concentration
Gentamicin-Amphotericin B Solution	0.5 mL	Gentamicin: 10 mg/mL Amphotericin B: 0.25 µg/mL
Penicillin-Streptomycin-Amphotericin B Solution	0.5 mL	Penicillin: 10 Units/mL Streptomycin: 10 µg/mL Amphotericin B: 25 ng/mL
Phenol Red	0.5 mL	33 µM

Tightly cap the bottle of complete growth medium and swirl the contents gently to assure a homogeneous solution. Do not shake forcefully to avoid foaming. Label and date the bottle.
Complete growth media should be stored in the dark at 2°C to 8°C (do not freeze). When stored under these conditions, complete growth media is stable for 30 days.

Volume	1 mL
Sterility Tests	Bacteria and Yeast: Negative Mycoplasma: Negative
Viral Testing	Hepatitis B: Negative Hepatitis C: Negative HIV-1: Negative HIV-2: Negative
Viability	≥ 50% when thawed from cryopreservation.
Population Doubling Capacity	≥ 15 in complete growth medium
C of A	Certificate of Analysis

Permits	These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation	Product Sheet Certificate of Analysis MSDS
Other Documentation	TransfeX protocol - DMVECs

Primary Dermal Microvascular Endothelial Cells; Normal, Human, Neonatal (ATCC® PCS-110-010™)

Share this product

Your session will expire in

Primary Dermal Microvascular Endothelial Cells; Normal, Human, Neonatal (ATCC^® PCS-110-010^™)